Dana-Farber scientist’s new startup aims for cancer drugs to be used during surgery


A scientist who trained under renowned chemical engineer Bob Langer and Nobel Prize-winning Biogen Inc. co-founder Phillip Sharp has ideas about how to transform cancer treatment.

Previous VA pushes back expansion of troubles Oracle Cerner system another six months
Next 'The market spoke back to us': Why this $21M Denver-area estate will try again next year